Annual Accounts Payable
$6.64 M
+$4.21 M+173.76%
December 31, 2023
Summary
- As of February 7, 2025, VERV annual accounts payable is $6.64 million, with the most recent change of +$4.21 million (+173.76%) on December 31, 2023.
- During the last 3 years, VERV annual accounts payable has risen by +$6.60 million (+18333.33%).
- VERV annual accounts payable is now -6.23% below its all-time high of $7.08 million, reached on December 31, 2021.
Performance
VERV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.64 M
-$2.20 M-32.14%
September 30, 2024
Summary
- As of February 7, 2025, VERV quarterly accounts payable is $4.64 million, with the most recent change of -$2.20 million (-32.14%) on September 30, 2024.
- Over the past year, VERV quarterly accounts payable has increased by +$3.58 million (+339.94%).
- VERV quarterly accounts payable is now -34.48% below its all-time high of $7.08 million, reached on December 31, 2021.
Performance
VERV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VERV Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +173.8% | +339.9% |
| 3 y3 years | +10000.0% | +339.9% |
| 5 y5 years | +175.2% | +339.9% |
VERV Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.2% | +173.8% | -34.5% | +897.2% |
| 5 y | 5-year | -6.2% | >+9999.0% | -34.5% | >+9999.0% |
| alltime | all time | -6.2% | >+9999.0% | -34.5% | >+9999.0% |
Verve Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.64 M(-32.1%) |
| Jun 2024 | - | $6.83 M(+124.1%) |
| Mar 2024 | - | $3.05 M(-54.1%) |
| Dec 2023 | $6.64 M(+173.8%) | $6.64 M(+529.6%) |
| Sep 2023 | - | $1.05 M(-66.5%) |
| Jun 2023 | - | $3.15 M(-6.7%) |
| Mar 2023 | - | $3.37 M(+39.1%) |
| Dec 2022 | $2.42 M | $2.42 M(+421.3%) |
| Sep 2022 | - | $465.00 K(-92.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $6.32 M(+159.2%) |
| Mar 2022 | - | $2.44 M(-65.6%) |
| Dec 2021 | $7.08 M(>+9900.0%) | $7.08 M(+97.7%) |
| Sep 2021 | - | $3.58 M(+133.9%) |
| Jun 2021 | - | $1.53 M(-38.5%) |
| Mar 2021 | - | $2.49 M(+6808.3%) |
| Dec 2020 | $36.00 K(-98.5%) | - |
| Dec 2020 | - | $36.00 K |
| Dec 2019 | $2.41 M | - |
FAQ
- What is Verve Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Verve Therapeutics?
- What is Verve Therapeutics annual accounts payable year-on-year change?
- What is Verve Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Verve Therapeutics?
- What is Verve Therapeutics quarterly accounts payable year-on-year change?
What is Verve Therapeutics annual accounts payable?
The current annual accounts payable of VERV is $6.64 M
What is the all time high annual accounts payable for Verve Therapeutics?
Verve Therapeutics all-time high annual accounts payable is $7.08 M
What is Verve Therapeutics annual accounts payable year-on-year change?
Over the past year, VERV annual accounts payable has changed by +$4.21 M (+173.76%)
What is Verve Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VERV is $4.64 M
What is the all time high quarterly accounts payable for Verve Therapeutics?
Verve Therapeutics all-time high quarterly accounts payable is $7.08 M
What is Verve Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VERV quarterly accounts payable has changed by +$3.58 M (+339.94%)